Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Daphnetin capsules for lower limb lymphedema after gynecologic cancer surgery
ChiCTR2400082016Phase 4Not yet recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Mar 2024
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of daphnetin and aescuven in lymphedema (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoints: Difference in lower limb circumference, Gynecological Cancer Lymphedema Questionnaire and 2 more. Planned start Mar 2024; status: not yet recruiting.
02
Drugs
daphnetinaescuven
03
Conditions
lymphedema
Beyond the preview
Go deeper on ChiCTR2400082016.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400082016.